Pentagamavunon-1 Enhances the Anticancer Effects of Doxorubicin on Triple-Negative Breast Cancer Cells in Monolayers and 3D Cancer Spheroid Models
Abstract
BACKGROUND: The 4T1 cells, a triple-negative breast cancer (TNBC) cell line, exhibit high malignancy and metastatic potential. As a primary treatment for TNBC, doxorubicin has limitations, including drug resistance mechanisms and severe side effects such as cardiotoxicity. Pentagamavunone-1 (PGV-1) exhibits antiproliferative and antimetastatic effects, induces prometaphase arrest, triggers cell senescence, and enhances reactive oxygen species (ROS) modulation, which may help overcome doxorubicin resistance. The selective cytotoxicity of PGV-1 against cancer cells suggests that it has a role in reducing systemic toxicity. Therefore, in this study, the anticancer effects of doxorubicin combined with PGV-1 was investigated.
METHODS: Monolayer/2D and spheroid/3D models of 4T1 cells were used to assess the effects of PGV-1, doxorubicin, and their combination. MTT assay was used to evaluate the cytotoxicity, colony formation assay was used to measure persistent antiproliferative effects, and spheroid volume analysis was performed to assessed tumor growth inhibition. Senescence-associated beta-galactosidase (SA-β-gal) assay determined cellular senescence.
RESULTS: The combination of PGV-1 and doxorubicin significantly enhanced cytotoxicity, with IC50 values of 0.57 µM and 4.88 µM, respectively (p=0.000). A strong synergistic effect was observed, leading to persistent suppression of cancer cell proliferation and an 80% reduction in colony formation (p=0.007). In the 3D spheroid model, combination treatment significantly reduced spheroid volume (p=0.002) more effectively than monotherapy, indicating superior growth inhibition and cytotoxicity. It also increased SA-β-gal, the senescence marker (p=0.010).
CONCLUSION: The combination of PGV-1 and doxorubicin demonstrated potent anticancer effects in 4T1 monolayers and spheroid models by enhancing cytotoxicity and inducing cellular senescence. This combination confirmed its potential as a more effective therapeutic strategy.
KEYWORDS: 3D spheroid, 4T1 TNBC cell, doxorubicin, pentagamavunon-1, PGV-1, senescence
Full Text:
PDFReferences
Karim AM, Kwon JE, Ali T, Jang J, Ullah I, Lee YG, et al. Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies. Biochem Pharmacol. 2023; 212: 115545, CrossRef.
Widodo I, Dwianingsih EK, Aryandono T, Soeripto. Clinicopathological characteristic and prognostic significance of Indonesian triple negative breast cancer. Indones Biomed J. 2019; 11(3): 286-92, CrossRef.
Tester AM, Ruangpanit N, Anderson RL, Thompson EW. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits. Clin Exp Metastasis. 2000; 18(7): 553-60, CrossRef.
Boyle P. research article Triple-negative breast cancer : Epidemiological considerations and recommendations research article. 2012; 23(Suppl 6): 8-13, CrossRef.
Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016; 293(2): 247-69, CrossRef.
Manjunath M, Choudhary B. Triple-negative breast cancer: A run-through of features, classification and current therapies. Oncol Lett. 2021; 22(1), CrossRef.
Obidiro O, Battogtokh G, Akala EO. Triple negative breast cancer treatment options and limitations: Future outlook. Pharmaceutics. 2023; 15(7): 1796, CrossRef.
Garcia E, Luna I, Persad KL, Agopsowicz K, Jay DA, West FG, et al. Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition. Sci Rep. 2021; 11(1): 11757, CrossRef.
Hapsari NP, Rahmawati DR, Nugraheni N, Hanifa M, Satria D, Zaitun Hasibuan PA, et al. Africa leaf (Vernonia amygdalina Delille.) DCM extract synergistically supports growth suppression effect of doxorubicin on MCF7 and MCF7/HER2 with different effects on cell cycle progression and apoptosis evidence. J Appl Pharm Sci. 2024; 2024: 1-7, CrossRef.
Rahmawati DR, Nugraheni N, Hapsari NP, Hanifa M, Prasetyaningrum PW, Kastian RF, et al. Dichloromethane fraction of vernonia amygdalina delile synergistically enhances cytotoxicity of doxorubicin on 4T1 triple negative breast cancer cells through apoptosis induction and cell cycle modulation. Indones J Pharm. 2024; [article in press], CrossRef.
Zufairo SK, Rahmawati DR, Meiyanto E, Susidarti RA. Citrus sinensis peel extract synergistically enhances the cytotoxic effect of chemotherapeutic agents on HepG2 cells. Indones J Cancer Chemoprevention. 2024; 14(3): 151-9, CrossRef.
Putri AP, Rahmawati DR, Rahman FA, Meiyanto E, Ikawati M. Chromolaena odorata L. leaf extract elevates cytotoxicity of doxorubicin on 4T1 breast cancer cells. Indones J Cancer Chemoprevention. 2024; 14(3): 160-70, CrossRef.
Nicoletto RE, Ofner CM. Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells. Cancer Chemother Pharmacol. 2022; 89(3): 285-311, CrossRef.
Meredith AM, Dass CR. Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J Pharm Pharmacol. 2016; 68(6): 729-41, CrossRef.
Kibria G, Hatakeyama H, Akiyama K, Hida K, Harashima H. Comparative study of the sensitivities of cancer cells to doxorubicin, and relationships between the effect of the drug-efflux pump P-gp. Biol Pharm Bull. 2014; 37(12): 1926-35, CrossRef.
Cox J, Weinman S. Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepatic Oncol. 2016; 3(1): 57-9, CrossRef.
Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Farahani MV, Hushmandi K, et al. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discov Today. 2022; 27(2): 436-55, CrossRef.
Kaina B. DNA damage-triggered apoptosis: Critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol. 2003; 66(8): 1547-54, CrossRef.
Wang YA, Johnson SK, Brown BL, McCarragher LM, Al-Sakkaf K, Royds JA, et al. Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status. Int J Cancer. 2008; 123(7): 1536-44, CrossRef.
Park M, Kim D, Ko S, Kim A, Mo K, Yoon H. Breast cancer metastasis: Mechanisms and therapeutic implications. Int J Mol Sci. 2022; 23(12): 6806, CrossRef.
Rahmawati DR, Nurrochmad A, Jenie RI, Meiyanto E. The synergistic cytotoxic effect of pentagamavunon-1 (PGV-1) and curcumin correlates with the cell cycle arrest to induce mitotic catastrophe in 4T1 and T47D breast cancer cells. Indones Biomed J. 2023; 15(5): 318-27, CrossRef.
Da'i M, Jenie UA, Am S, Kawaichi M, Meiyanto E. T47D cells arrested at G2M and hyperploidy formation induced by a curcumin's analogue PGV-1. Indones J Biotechnol. 2007; 12(2): 1005-12, article.
Lestari B, Nakamae I, Yoneda-Kato N, Morimoto T, Kanaya S, Yokoyama T, et al. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. Sci Rep. 2019; 9(1): 14867, CrossRef.
Nugraheni N, Zulfin UM, Lestari B, Hapsari NP, Ikawati M, Utomo RY, et al. PGV-1 causes disarrangement of spindle microtubule organization resulting in aberrant mitosis in HLF and HuH6 cells associated with altered MYCN status. Adv Pharm Bull. 2024; 14(3): 665-74, CrossRef.
Rahmawati DR, Meiyanto E, Jenie RI, Nurrochmad A. Curcumin enhances antimigration of pentagamavunon-1 by suppressing MMP-2 and MMP-9 expression in triple-negative (4T1) and luminal A (T47D) breast cancer cells. Indones Biomed J. 2025; 17(1): 34-42, CrossRef.
Utomo RY, Wulandari F, Novitasari D, Lestari B, Susidarti RA, Jenie RI, et al. Preparation and cytotoxic evaluation of PGV-1 derivative, CCA-1.1, as a new curcumin analog with improved-physicochemical and pharmacological properties. Adv Pharm Bull. 2022; 12(3): 603-12, CrossRef.
Riffle S, Pandey RN, Albert M, Hegde RS. Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids. BMC Cancer. 2017; 17(1): 338. doi: 10.1186/s12885-017-3319-0, CrossRef.
Leedale J, Colley HE, Gaskell H, Williams DP, Bearon RN, Chadwick AE, et al. In silico-guided optimisation of oxygen gradients in hepatic spheroids. Comput Toxicol. 2019; 12: 100093, CrossRef.
Leek R, Grimes DR, Harris AL, McIntyre A. Methods: Using three-dimensional culture (spheroids) as an in vitro model of tumour hypoxia. Adv Exp Med Biol. 2016; 899: 167-96, CrossRef.
Świerczewska M, Sterzyńska K, Ruciński M, Andrzejewska M, Nowicki M, Januchowski R. The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids. Biomed Pharmacother. 2023; 165: 115152, CrossRef.
Santoso CF, Rahmawati DR, Nugraheni N, Rahmadhany M. Chemopreventive properties curcuma heyneana rhizome ethanolic extract on hepatocellular carcinoma cells. JHH-4. Indones J Cancer Chemoprev. 2024; 15(1): 40-9, CrossRef.
Meiyanto E, Putri DDP, Susidarti RA, Murwanti R, Sardjiman, Fitriasari A, et al. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation. Asian Pacific J Cancer Prev. 2014; 15(1): 179-84, CrossRef.
Widowati W, Jasaputra DK, Sumitro SB, Widodo MA, Afifah E, Rizal R, et al. Direct and indirect effect of TNFα and IFNγ toward apoptosis in breast cancer cells. Mol Cell Biomed Sci. 2018; 2(2): 60-9, CrossRef.
Meiyanto E, Melannisa R, Da'i M. PGV-1 menurunkan ekspresi faktor angiogenesis (VEGF dan COX-2) pada sel T47D terinduksi estrogen. Indones J Pharm. 2006; 17(1): 1-6, CrossRef.
Pinto B, Henriques AC, Silva PMA, Bousbaa H. Three-dimensional spheroids as in vitro preclinical models for cancer research. Pharmaceutics. 2020; 12(12): 1186, CrossRef.
Rovere M, Reverberi D, Arnaldi P, Palamà MEF, Gentili C. Spheroid size influences cellular senescence and angiogenic potential of mesenchymal stromal cell-derived soluble factors and extracellular vesicles. Front Bioeng Biotechnol. 2023; 11: 1297644, CrossRef.
Chou R zeng LL fang. Dynamic analysis of hepatoma spheroid formation : roles of E-cadherin and β 1-integrin. Cell Tissue Res. 2006; 324(3): 411-22, CrossRef.
Bonafè F, Pazzini C, Marchionni S, Guarnieri C, Muscari C. Complete disaggregation of MCF-7-derived breast tumour spheroids with very low concentrations of α-mangostin loaded in CD44 thioaptamer-tagged nanoparticles. Int J Med Sci. 2019; 16(1): 33-42, CrossRef.
Biosensors C based, Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. 2014; 12(4): 207-18, CrossRef.
Murwanti R, Kholifah E, Ari Sudarmanto BS, Hermawan A. Curcumin and its analogue targeting β-catenin and gsk-3β in wnt signaling pathways: In vitro and in silico study. Res J Pharm Technol. 2020; 13(4): 1715-9, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i3.3587
Copyright (c) 2025 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
